2022 marks the Tenth Anniversary of TransCelerate. 150 current and past members, contributors, and other industry stakeholders from around the world convened at the Franklin Institute in Philadelphia on October 6, 2022, to celebrate. At its founding, TransCelerate’s goal was to tackle five persistent issues in clinical trials: development of a shared user interface for…
Welcome to TransCelerate
TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines.
Janice Chang Appointed New CEO of TransCelerate BioPharma
Janice Chang has been appointed as TransCelerate’s new Chief Executive Officer. Currently serving as Chief Operating Officer, Janice will assume the role on January 1, 2023. She will also serve as CEO of BioCelerate.
TransCelerate & ACRO release points to consider when developing a CSR in unforeseen circumstances
Both ACRO and TransCelerate Member Companies have faced unprecedented interruptions to clinical trials caused by an increasingly diverse set of circumstances. The two organizations have taken the lessons learned from the past three years and published a proposal on how to address these challenges.
Digital Data Flow Launches Open Source SDR Reference Implementation
The Digital Data Flow Initiative released a Study Definition Repository Reference Implementation Minimal Viable Product, which is a model implementation of a repository that uses a Unified Study Definitions Model to facilitate data exchange. The source code and configurations are available by means of an open-source license, enabling pre-production deployments by solution providers or individual study sponsors.
Join TransCelerate's Awareness & Implementation Community
TransCelerate's mission can only be realized when the benefits that stem from its solution adoption are being felt by stakeholders across the R&D ecosystem. By signing up for this community, you'll be the first to learn about new solutions, educational webinars, testimonials, and more.
GCP Mutual Recognition
The TransCelerate Site Qualification and Training (SQT) Initiative has developed a Mutual Recognition (MR) Program for ICH E6 Good Clinical Practice (GCP) Training, targeted to investigator site personnel. Our GCP Mutual Recognition program was created to reduce redundant training and hours spent by investigators who need to complete the same training if they work with multiple sponsors.
TransCelerate Member Companies have translated select solutions for potential use within the broader global community. Current translations include solutions concerning Common Protocol Template, Site Qualification & Training, Quality Management Systems and Patient Experience.
- Welcome to TransCelerate
- Janice Chang Appointed New CEO of TransCelerate BioPharma
- TransCelerate & ACRO release points to consider when developing a CSR in unforeseen circumstances
- Digital Data Flow Launches Open Source SDR Reference Implementation
- Join TransCelerate's Awareness & Implementation Community
- GCP Mutual Recognition
- Translated Solutions